This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.

Panelists

User Photo

Martin Colla

Panelist

Work Location

  • France

Organization

  • Cepheid, Inc.

Bio

Dr Christopher Gilpin has over twenty years experience as a Microbiology Laboratory Scientist managing diagnostic laboratories in Australia and the Middle-East. Chris completed studies in England for his doctorate in the molecular diagnosis and epidemiology of tuberculosis and was formerly Head of the TB Supranational Reference Laboratory in Brisbane, Australia. He has extensive experience in TB laboratory capacity strengthening and training in Africa, Asia and in the Pacific Islands. Chris holds a master of Public Health degree focused on tuberculosis and migration. He relocated to Geneva, Switzerland in 2007 to work as the Global Laboratory Manager for the International Organization for Migration and is currently employed by the World Health Organization as a Scientist in TB Diagnostics and Laboratory Strengthening Unit (TBL) of the StopTB Department. Chris is part of the team at WHO leading the roll-out of recently endorsed Xpert MTB/RIF assay.

Work Location

  • Switzerland

Organization

  • World Health Organization - WHO

Bio

TB-HIV Adviser Southern Africa Medical Unit (SAMU) Operational Centre Brussels (OCB) Médecins Sans Frontières / Doctors Without Borders (MSF)

Work Locations

  • Canada
  • India
  • South Africa

Organization

  • Doctors Without Borders/Médecins Sans Frontières - MSF
User Photo

Wendy Stevens

Panelist

Work Location

  • South Africa

Organization

  • National Health Laboratory Services - NHLS, South Africa

Bio

Source photo: http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-armand-van-deun/

Work Location

  • Belgium

Organizations

  • Institute of Tropical Medicine, Antwerp - ITM
  • International Union Against Tuberculosis and Lung Disease (The Union)